Concepedia

Identification of CDK10 as an Important Determinant of Resistance to Endocrine Therapy for Breast Cancer

Elizabeth Iorns, Nicholas C. Turner, Richard Elliott, Nelofer Syed, Ornella Garrone, Milena Gasco, Andrew Tutt, Tim Crook, Christopher J. Lord, Alan Ashworth

Cancer Cell · 2008 · 228 citations · 28 references

DOIFull text

Open access

Concepts

References

28

Tamoxifen for early breast cancer: an overview of the randomised trials

The Lancet · 1998 · 4.1K citations

, , +9

Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

C. Focan, S. M. Steinberg, M Blichert-Toft et al. · PubMed · 1998 · 2.2K citations

, , +5

Cyclin D1 Expression Is Regulated Positively by the p42/p44 and Negatively by the p38/HOG Pathway

Josée N. Lavoie, Gilles L’Allemain, Anne Brunet et al. · Journal of Biological Chemistry · 1996 · 1.2K citations · Full text

, , +17

Mechanisms of Tamoxifen Resistance: Increased Estrogen Receptor-HER2/neu Cross-Talk in ER/HER2-Positive Breast Cancer

Jianzhong Shou, Suleiman Massarweh, C. K. Osborne et al. · JNCI Journal of the National Cancer Institute · 2004 · 1.2K citations · Full text

, , +17

TRANSFAC: a database on transcription factors and their DNA binding sites

Edgar Wingender · Nucleic Acids Research · 1996 · 1.1K citations · Full text

, , +17